This association appears to be in accordance with the findings of Diekstra et al., whose study correlated ABCB1 1236 TT and ABCB1 2677 TT to increased clearance of sunitinib and its active metabolite in 114 cancer patients using univariate analyses that did not include demographic covariates [25]. The gene discussed is ABCB1; the disease is cancer.